Check out Karen's recent publications:
Webinar on Key Regulatory Considerations for Cell and Gene Therapy Products 2021
Webinar presentation from Karen Magers, Global Head of Regulatory, Cell & Gene Technologies on the latest and most important regulatory considerations in the pathway to commercialization of cell & gene therapy products
Meeting regulatory requirements for cell and gene therapy manufacturing
Existing regulatory landscape, guidance and regulations applicable to cell and gene therapy products, hot topics related to manufacturing facilities to be considered during regulatory filings, Segregation measures and controls.